Bacillus anthracis lethal toxin reduces human alveolar epithelial barrier function

Infection and Immunity

Volumn 80, Issue 12, 2012, Pages 4374-4387

  Langer, Marybeth ^a   Duggan, Elizabeth Stewart ^a   Booth, John Leland ^a   Patel, Vineet Indrajit ^a   Zander, Ryan A ^a   Silasi Mansat, Robert ^b   Ramani, Vijay ^c   Veres, Tibor Zoltan ^d   Prenzler, Frauke ^e   Sewald, Katherina ^e   Williams, Daniel M ^f   Coggeshall, Kenneth Mark ^b   Awasthi, Shanjana ^c   Lupu, Florea ^b   Burian, Dennis ^f   Ballard, Jimmy Dale ^a   Braun, Armin ^e   Metcalf, Jordan Patrick ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF TURKU   (Finland)

^e FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

^f CIVIL AEROSPACE MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ANTHRAX TOXIN; BACILLUS ANTHRACIS LETHAL TOXIN; MITOGEN ACTIVATED PROTEIN KINASE; PURINERGIC P2X7 RECEPTOR; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; DESMOSOME; EDEMA; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOLOCALIZATION; LETHAL GENE; LUNG ALVEOLUS EPITHELIUM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TIGHT JUNCTION;

ACTINS; ANIMALS; ANTHRAX; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; CALCIUM-BINDING PROTEINS; CELLS, CULTURED; HUMANS; MEMBRANE PROTEINS; MICE; MIXED FUNCTION OXYGENASES; MUSCLE PROTEINS; PNEUMOCYTES; RECEPTORS, PEPTIDE; RESPIRATORY TRACT INFECTIONS; VIRULENCE;

EID: 84870769887     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01011-12     Document Type: Article

References (67)

1. Aggarwal S, Suzuki T, Taylor WL, Bhargava A, Rao RK. 2011. Contrasting effects of ERK on tight junction integrity in differentiated and under-differentiated Caco-2 cell monolayers. Biochem. J. 433:51-63.
2. Bachofen M, Weibel ER. 1977. Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. Am. Rev. Respir. Dis. 116:589-615.
3. Barakat LA, et al. 2002. Fatal inhalational anthrax in a 94-year-old Connecticut woman. JAMA 287:863-868.
4. Barbee RW, Perry BD, Re RN, Murgo JP. 1992. Microsphere and dilution techniques for the determination of blood flows and volumes in conscious mice. Am. J. Physiol. 263:R728-R733.
5. Bligh EG, Dyer WJ. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
6. Bonuccelli G, et al. 2005. ATR/TEM8 is highly expressed in epithelial cells lining Bacillus anthracis' three sites of entry: implications for the patho-genesis of anthrax infection. Am. J. Physiol. Cell Physiol. 288:C1402-C1410.
7. Borio L, et al. 2001. Death due to bioterrorism-related inhalational anthrax: report of 2 patients. JAMA 286:2554-2559.
8. Boyer AE, et al. 2009. Kinetics of lethal factor and poly-D-glutamic acid antigenemia during inhalation anthrax in rhesus macaques. Infect. Immun. 77:3432-3441.
9. Bresgen N, et al. 2008. Ferritin and FasL (CD95L) mediate density dependent apoptosis in primary rat hepatocytes. J. Cell. Physiol. 217:800-808.
10. Brookmeyer R, Johnson E, Barry S. 2005. Modelling the incubation period of anthrax. Stat. Med. 24:531-542.
11. Chakrabarty K, et al. 2006. Bacillus anthracis spores stimulate cytokine and chemokine innate immune responses in human alveolar macrophages through multiple mitogen-activated protein kinase pathways. Infect. Immun. 74:4430-4438.
12. Chen J, Chen Z, Narasaraju T, Jin N, Liu L. 2004. Isolation of highly pure alveolar epithelial type I and type II cells from rat lungs. Lab. Invest. 84:727-735.
13. Chen Z, et al. 2004. Identification of two novel markers for alveolar epithelial type I and II cells. Biochem. Biophys. Res. Commun. 319:774-780.
14. Chuang CY, et al. 2011. Toll-like receptor 2-mediated sequential activation of MyD88 and MAPKs contributes to lipopolysaccharide-induced sp-a gene expression in human alveolar epithelial cells. Immunobiology 216:707-714.
15. Crapo JD, Barry BE, Gehr P, Bachofen M, Weibel ER. 1982. Cell number and cell characteristics of the normal human lung. Am. Rev. Respir. Dis. 125:740-745.
16. Cunningham AC, et al. 1994. Constitutive expression of MHC and adhesion moleculesbyalveolar epithelial cells (type IIpneumocytes) isolated from human lung and comparison with immunocytochemical findings. J. Cell Sci. 107(Part 2):443-449.
17. Dobbs LG, Gonzalez RF, Allen L, Froh DK. 1999. HTI56, an integral membrane protein specific to human alveolar type I cells. J. Histochem. Cytochem. 47:129-137.
18. Dudek SM, Garcia JG. 2001. Cytoskeletal regulation of pulmonary vascular permeability. J. Appl. Physiol. 91:1487-1500.
19. During RL, et al. 2007. Anthrax lethal toxin paralyzes actin-based motil-ity by blocking Hsp27 phosphorylation. EMBO J. 26:2240-2250.
20. Elbert KJ, et al. 1999. Monolayers of human alveolar epithelial cells in primary culture for pulmonary absorption and transport studies. Pharm. Res. 16:601-608.
21. Ezzell JW, Ivins BE, Leppla SH. 1984. Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin. Infect. Immun. 45: 761-767.
22. Fang X, et al. 2006. Contribution of CFTR to apical-basolateral fluid transportincultured human alveolar epithelial typeIIcells. Am. J.Physiol. Lung Cell. Mol. Physiol. 290:L242-L249.
23. Friedlander AM, Bhatnagar R, Leppla SH, Johnson L, Singh Y. 1993. Characterization of macrophage sensitivity and resistance to anthrax lethal toxin. Infect. Immun. 61:245-252.
24. Fuchs S, et al. 2003. Differentiation of human alveolar epithelial cells in primary culture: morphological characterization and synthesis of caveolin-1 and surfactant protein-C. Cell Tissue Res. 311:31-45.
25. Garcia JG, et al. 2001. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J. Clin. Invest. 108:689-701.
26. Guidi-Rontani C. 2002. The alveolar macrophage: the Trojan horse of Bacillus anthracis. Trends Microbiol. 10:405.
27. Gutierrez-Canas I, et al. 2003. VIP and PACAP are autocrine factors that protect the androgen-independent prostate cancer cell line PC-3 from apoptosis induced by serum withdrawal. Br. J. Pharmacol. 139:1050-1058.
28. Hartsock A, Nelson WJ. 2008. Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim. Biophys. Acta 1778:660-669.
29. Hattersley SM, Greenman J, Haswell SJ. 2011. Study of ethanol induced toxicity inliver explants using microfluidic devices. Biomed. Microdevices 13:1005-1014.
30. Kikkawa Y, Yoneda K. 1974. The type II epithelial cell of the lung. I. Method of isolation. Lab. Invest. 30:76-84.
31. Kuo SR, et al. 2008. Anthrax toxin-induced shock in rats is associated with pulmonary edema and hemorrhage. Microb. Pathog. 44:467-472.
32. Lehmann M, Noack D, Wood M, Perego M, Knaus UG. 2009. Lung epithelial injury by B. anthracis lethal toxin is caused by MKK-dependent loss of cytoskeletal integrity. PLoS One 4:e4755. doi:10.1371/journal.pone.0004755.
33. Lipschutz JH, Li S, Arisco A, Balkovetz DF. 2005. Extracellular signal-regulated kinases 1/2 control claudin-2 expression in Madin-Darby canine kidney strain I and II cells. J. Biol. Chem. 280:3780-3788.
34. Liu S, et al. 2009. Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo. Proc. Natl. Acad. Sci. U.S.A. 106:12424-12429.
35. Liu S, et al. 2010. Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of Bacillus anthracis infections in mice. Cell Host Microbe 8:455-462.
36. -δδCT method. Methods 25: 402-408.
37. Lupu C, et al. 1999. Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture. Arterioscler. Thromb. Vasc. Biol. 19:2251-2262.
38. Lyons CR, et al. 2004. Murine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibility. Infect. Immun. 72:4801-4809.
39. Mabry R, et al. 2006. Detection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassays. Clin. Vaccine Immunol. 13:671-677.
40. Matthay MA, Zemans RL. 2011. The acute respiratory distress syndrome: pathogenesis and treatment. Annu. Rev. Pathol. 6:147-163.
41. Moayeri M, Haines D, Young HA, Leppla SH. 2003. Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice. J. Clin. Invest. 112:670-682.
42. Moayeri M, Leppla SH. 2009. Cellular and systemic effects of anthrax lethal toxin and edema toxin. Mol. Aspects Med. 30:439-455.
43. Mueller H, Franke WW. 1983. Biochemical and immunological characterization of desmoplakins I and II, the major polypeptides of the desmo-somal plaque. J. Mol. Biol. 163:647-671.
44. Nizet V, et al. 1996. Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells. Infect. Immun. 64:3818-3826.
45. Papadimitriou E, et al. 2012. Differential regulation of the two RhoA-specific GEF isoforms Net1/Net1A by TGF-beta and miR-24: role in epithelial-to-mesenchymal transition. Oncogene 31:2862-2875.
46. Park JM, Greten FR, Li ZW, Karin M. 2002. Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 297: 2048-2051.
47. Peifer M, McCrea PD, Green KJ, Wieschaus E, Gumbiner BM. 1992. The vertebrate adhesive junction proteins beta-catenin and plakoglobin and the Drosophila segment polarity gene armadillo form a multigene family with similar properties. J. Cell Biol. 118:681-691.
48. Rao JY, et al. 1990. Cellular F-actin levels as a marker for cellular transformation: relationship to cell division and differentiation. Cancer Res. 50:2215-2220.
49. Richards RJ, Davies N, Atkins J, Oreffo VI. 1987. Isolation, biochemical characterization, and culture of lung type II cells of the rat. Lung 165:143-158.
50. Ridsdale R, Na CL, Xu Y, Greis KD, Weaver T. 2011. Comparative proteomic analysis of lung lamellar bodies and lysosome-related organ-elles. PLoS One 6:e16482. doi:10.1371/journal.pone.0016482.
51. Rolando M, et al. 2009. Injection of Staphylococcus aureus EDIN by the Bacillus anthracis protective antigen machinery induces vascular permeability. Infect. Immun. 77:3596-3601.
52. Rolando M, et al. 2010. Transcriptome dysregulation by anthrax lethal toxin plays a key role in induction of human endothelial cell cytotoxicity. Cell Microbiol. 12:891-905.
53. Ross JM. 1957. The pathogenesis of anthrax following the administration of spores by the respiratory route. J. Pathol. Bacteriol. 73:485.
54. Silva MT. 2010. Secondary necrosis: the natural outcome of the complete apoptotic program. FEBS Lett. 584:4491-4499.
55. Stewart JC. 1980. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal. Biochem. 104:10-14.
56. Strengert M, Knaus UG. 2011. Analysis of epithelial barrier integrity in polarized lung epithelial cells, p 195-206. In Turksen K (ed), Permeability barrier: methods and protocols, vol 763. Springer, New York, NY.
57. Uhal BD, Rannels SR, Rannels DE. 1989. Flow cytometric identification and isolation of hypertrophic type II pneumocytes after partial pneumo-nectomy. Am. J. Physiol. 257:C528-C536.
58. Vanden Berghe T, et al. 2010. Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features. Cell Death Differ. 17:922-930.
59. Vesterdal LK, et al. 2012. Carbon black nanoparticles and vascular dysfunction in cultured endothelial cells and artery segments. Toxicol. Lett. 214:19-26.
60. Wang J, et al. 2007. Differentiated human alveolar epithelial cells and reversibility of their phenotype in vitro. Am. J. Respir. Cell Mol. Biol. 36:661-668.
61. Wang Y, Zhang J, Yi XJ, Yu FS. 2004. Activation of ERK1/2 MAP kinase pathway induces tight junction disruption in human corneal epithelial cells. Exp. Eye Res. 78:125-136.
62. Warfel JM, Steele AD, D'Agnillo F. 2005. Anthrax lethal toxin induces endothelial barrier dysfunction. Am. J. Pathol. 166:1871-1881.
63. Witherden IR, Tetley TD. 2001. Isolation and culture of human alveolar type II pneumocytes. Methods Mol. Med. 56:137-146.
64. Wu W, et al. 2009. Resistance of human alveolar macrophages to Bacillus anthracis lethal toxin. J. Immunol. 183:5799-5806.
65. Wu X, Molinaro C, Johnson N, Casiano CA. 2001. Secondary necrosis is a source of proteolytically modified forms of specific intracellular autoan-tigens: implications for systemic autoimmunity. Arthritis Rheum. 44: 2642-2652.
66. Yang L, et al. 2010. Surfactant protein B propeptide contains a saposin-like protein domain with antimicrobial activity at low pH. J. Immunol. 184:975-983.
67. Zar JH. 1996. Biostatistical analysis. Prentice-Hall, Englewood Cliffs, NJ.